A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Tóm tắt
Từ khóa
Tài liệu tham khảo
Omland LH, 2010, Mortality in patients with chronic and cleared hepatitis C viral infection, a nationwide cohort study, 53, 36
Muhlberger N, 2009, HCV‐related burden of disease in Europe, a systematic assessment of incidence, prevalence, morbidity, and mortality, 9, 34
Davis GL, 2010, Aging of hepatitis C virus (HCV)‐infected persons in the United States, a multiple cohort model of HCV prevalence and disease progression, 138, 513
Chiquete E, 2007, Low prevalence of anti‐hepatitis C virus antibodies in Mexico, a systematic review, 50, 1
Rantala M, 2008, Surveillance and epidemiology of hepatitis B and C in Europe – a review, Euro Surveill, 13, 1, 10.2807/ese.13.21.18880-en
European Centre for Disease Prevention and Control., 2010, Annual Epidemiological Report on Communicable Diseases in Europe 2009. Report on the State of Communicable Diseases in Europe 2009, Revised Edition
Remis RS., 2009, Modelling the Incidence and Prevalence of Hepatitis C Infection and Its Sequelae in Canada, 2007: Final Report
Enhanced Hepatitis Strain Surveillance System., 2009, Health Canada. Epidemiology of Acute Hepatitis C Infection in Canada. Results from the Enhanced Hepatitis Strain Surveillance System (EHSSS)
Public Health Agency of Canada., 2008, Evaluation of the Hepatitis C Prevention, Support and Research Program 1999/2000–2005/2006
Remis Robert S., 2008, A Study to Characterize the Epidemiology of Hepatitis C Infection in Canada, 2002: Final Report/Prepared by Robert S. Remis Computer File
Manuel DG, 1999, The prevalence of hepatitis C in a community‐based population, Ontario, 1996, Can Commun Dis Rep, 25, 193
Public Health Agency of Canada.Notifiable Diseases Online 2005 1991–2004. Available athttp://dsol‐smed.hc‐sc.gc.ca/dsol‐smed/ndis/c_inda‐eng.php
Marotta P, 2008, Impact of advanced fibrosis and cirrhosis on sustained virologic response of HCV G1‐infected patients: results of the Canadian power program (Abstract #1216). 58th annual meeting of the American Association for the Study of Liver Diseases, 31 October–4 November 2008. San Francisco, California, USA, Hepatology, 48, 849A
Chaudhary RK, 1999, Distribution of hepatitis C virus genotypes in Canada, results from the LCDC Sentinel Health Unit Surveillance System, 10, 53
Bernier L, 1996, Identification of numerous hepatitis C virus genotypes in Montreal, Canada, J Clin Microbiol, 34, 2815, 10.1128/jcm.34.11.2815-2818.1996
Murphy DG, 1995, Hepatitis C virus genotypes in patients and blood donors – Quebec, Can Commun Dis Rep, 21, 129
Andonov A, 1994, Genotyping of Canadian hepatitis C virus isolates by PCR, J Clin Microbiol, 32, 2031, 10.1128/jcm.32.8.2031-2034.1994
FrankovaS.Department of Hepatogastroenterology Institute for Clinical and Experimental Medicine Prague Czech Republic. Screening for hepatitis C in the Czech Republic. Conversation with Largen A Center for Disease Analysis Kromite Louisville CO USA 14 November 2010.
Krekulova L, 2009, Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic, Epidemiol Mikrobiol Imunol, 58, 84
Urbanek P, 2002, Risk factors for transmission of hepatitis C in the the Czech population, Cas Lek Cesk, 141, 185
Hobstova J, 2007, Infectious diseases of drug users in the Czech Republic, Cas Lek Cesk, 146, 137
Nemecek V, 2003, The 2001 serological survey in the Czech Republic – viral hepatitis, Cent Eur J Public Health, 11, S54
Klofera M, 1994, Hepatitis C antibodies (anti‐HCV) in blood donors at the transfusion department in Brno, Cas Lek Cesk, 133, 459
Nemecek V, 2009, Genotypic heterogeneity of hepatitis C virus (HCV) from blood donors in the Czech Republic, Epidemiol Mikrobiol Imunol, 58, 63
Delarocque‐Astagneau E, 2010, The impact of the prevention programme of hepatitis C over more than a decade, the French experience, 17, 435
Jullien‐Depradeux AM, 2002, National campaign against hepatitis C in France (1999–2002), Acta Gastroenterol Belg, 65, 112
Dubois F, 1997, Hepatitis C in a French population‐based survey, 1994, seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group, 25, 1490
Meffre C, 2010, Prevalence of hepatitis B and hepatitis C virus infections in France in 2004, social factors are important predictors after adjusting for known risk factors, 82, 546
Foucher J, 2009, FibroScan used in street‐based outreach for drug users is useful for hepatitis C virus screening and management, a prospective study, 16, 121
Michault A, 2000, Prevalence of hepatitis A, B, C virus markers in Reunion (south hospital and Saint Pierre prison), Bull Soc Pathol Exot, 93, 34
Nalpas B, 2000, Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption, Gastroenterol Clin Biol, 24, 536
Ouzan D, 2000, Epidemiological information obtained from anti‐hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes‐Maritimes region, Gastroenterol Clin Biol, 24, 337
Pradat P, 2000, HCV, epidemiology, modes of transmission and prevention of spread, 14, 201
Frere T, 1999, Treatment of hepatitis C virus infection in the Poitou‐Charentes region, Gastroenterol Clin Biol, 23, 887
Merle V, 1999, Risk factors of contamination by hepatitis C virus. Case–control study in the general population, Gastroenterol Clin Biol, 23, 439
Raguin G, 1998, Hepatitis C in France, a national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases), 14, 545
Bastie A, 1995, Hepatitis C virus infection. Epidemiology, Pathol Biol, 43, 674
Maisonneuve P, 1991, Serum antibodies to hepatitis C virus, analysis of risk factors of seropositivity in a population of blood donors in metropolitan France, 12, 416
Roudot‐Thoraval F., 1996, Epidemiology of infections linked to hepatitis C virus in France, Bull Acad Natl Med, 180, 1253
French Institute for Public Health Surveillance (InVS).Institut de veille sanitaire. Hepatite C. Surveillance nationale de l'hepatite C a partir des poles de reference volontaires. Donnees 2001–2007.2010 Available athttp://www.invs.sante.fr/surveillance/hepatite_c/poleref_volontaire/2001_2007/web‐2007v2.pdf(accessed 28 September 2010).
Defossez G, 2008, Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003, a comparative cross-sectional study in Poitou-Charentes region, 20, 367
Martinot‐Peignoux M, 1999, Hepatitis C virus genotypes in France, relationship with epidemiology, pathogenicity and response to interferon therapy. The GEMHEP, 6, 435
Payan C, 2005, Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium, The GEMHEP GenoCII Study, 12, 405
Desenclos JC., 2000, Epidemiology of hepatitis C, Rev Prat, 50, 1066
Jauffret‐Roustide M, 2009, A national cross‐sectional study among drug‐users in France, epidemiology of HCV and highlight on practical and statistical aspects of the design, 9, 113
Jauffret‐Roustide M, 2006, Limited impact of the harm‐reduction policy on HCV among drug‐users. The ANRS‐Coquelicot survey example, Rev Epidemiol Sante Publique, 54, 1S53
Aymard JP, 1993, Seroprevalence of hepatitis C antibodies among blood donors. Study of second generation ELISA and RIBA tests and surrogate markers, Pathol Biol, 41, 149
Aymard JP, 1990, Serum antibodies against hepatitis C, study of 4,100 blood donors from the northeast of France, 33, 295
Larsen C, 2008, Prevalence of hepatitis C and hepatitis B infection in the HIV‐infected population of France, 2004, Euro Surveill, 13, 1, 10.2807/ese.13.22.18888-en
Ouzan D, 2003, Modalities of care in anti HCV positive patients identified in General Medicine in the Alpes‐Maritimes district, Gastroenterol Clin Biol, 27, 376
Roudot‐Thoraval F, 2000, Strategies of hepatitis C screening in general practice. Results of a two‐center randomized trial, Gastroenterol Clin Biol, 24, 1037
Djeriri K, 1996, Seroprevalence of markers of viral hepatitis A, B and C in hospital personnel at the Clermont‐Ferrand University Hospital Center, Presse Med, 25, 145
Roudot‐Thoraval F, 1992, Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France, Gastroenterol Clin Biol, 16, 255
Bruandet A, 2006, Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France, Rev Epidemiol Sante Publique, 54, 1S15
Tamalet C, 2003, Genomic and phylogenetic analysis of hepatitis C virus isolates, a survey of 535 strains circulating in southern France, 71, 391
Bourliere M, 2002, Epidemiological changes in hepatitis C virus genotypes in France, evidence in intravenous drug users, 9, 62
Elghouzzi MH, 2000, Hepatitis C virus, routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors, 79, 138
Sarrazin C, 2010, Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection, the German guidelines on the management of HCV infection, 48, 289
Robert Koch Institute., 2010, Zur Situation wichtiger Infektionskrankheiten in Deutschland, virus hepatitis B, C und D im Jahr 2009, 20, 177
Offergeld R, 2005, Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000–2002, risk of virus transmission and the impact of nucleic acid amplification testing, 10, 8
Deterding K, 2009, The German Hep‐Net acute hepatitis C cohort, impact of viral and host factors on the initial presentation of acute hepatitis C virus infection, 47, 531
Ammon A, 2000, Hepatitis B and C among Berlin dental personnel, incidence, risk factors, and effectiveness of barrier prevention measures, 125, 407
SchlosserB DomkeD MockelM.High prevalence of chronic hepatitis C virus (HCV) infection in a German metropolitan area: a prospective screening analysis of 13 823 patients. The International Liver Congress 2009 44th Annual Meeting of the European Association for the Study of the Liver 22–26 April 2009 Copenhagen Denmark Poster (PDF) 2009.
Backmund M, 2003, Hepatitis C virus infection in injection drug users in Bavaria, risk factors for seropositivity, 18, 563
Wiegand J, 2009, Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany, epidemiological benefit from established health resources, 16, 743
Seidl S, 1990, Hepatitis C virus (HCV) antibodies in German blood donors – a pilot study, Beitr Infusionsther, 26, 18
Zimmermann R, 1992, Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti‐HCV test and for circulating HCV‐RNA using polymerase chain reaction, Beitr Infusionsther, 30, 38
The Hepatitis C Trust., 2006, University of Southampton. The UK vs. Europe: Losing the fight against hepatitis C
Schroter M, 2002, Epidemiological dynamics of hepatitis C virus among 747 German individuals, new subtypes on the advance, 40, 1866
Ross RS, 2000, Genotyping of hepatitis C virus isolates using CLIP sequencing, J Clin Microbiol, 38, 3581, 10.1128/JCM.38.10.3581-3584.2000
Berg T, 1997, Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C, correlation with clinical and virological parameters, 26, 484
Katsoulidou A, 2006, Molecular epidemiology of hepatitis C virus (HCV) in Greece, temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates, 13, 19
Raptopoulou M, 2011, Significant epidemiological changes in chronic hepatitis C infection, results of the nationwide HEPNET-GREECE cohort study, 15, 26
Goritsas C, 2000, HCV infection in the general population of a Greek island, prevalence and risk factors, 47, 782
Zervou EK, 2003, Low prevalence of HCV, HIV, and HTLV‐I/II infection markers in northwestern Greece, results of a 3-year prospective donor study (1995–1997), 14, 39
Koulentaki M, 2001, Prevalence of hepatitis B and C markers in high‐risk hospitalised patients in Crete, a five-year observational study, 1, 17
Sypsa V, 2004, Reconstructing and predicting the hepatitis C virus epidemic in Greece, increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection, 11, 366
Barna TK, 1996, Hepatitis C virus antibody in the serum of blood donors, Orv Hetil, 137, 507
MerkinaiteS.HCV infection in Europe. Siauliu St. 5/1‐21 Vilnius 01133 Lithuania: Eurasian Harm Reduction Network (EHRN) formerly Central and Eastern European Harm Reduction Network (CEEHRN) 1 October 2007.
European Monitoring Centre for Drugs and Drug Addiction., 2010, EMCDDA 2010 Selected Issue‐Trends in Injecting Drug use in Europe European Union. Annual Report. Selected Issues/European Monitoring Centre for Drugs and Drug Addicton
McOmish F, 1994, Geographical distribution of hepatitis C virus genotypes in blood donors, an international collaborative survey, 32, 884
Gervain J, 2001, Determination of the type and subtype of the hepatitis C virus in chronic viral hepatitis patients in Hungary, Orv Hetil, 142, 1315
SarvariC UjhelyiE SzlávikJ et alDetermination of hepatitis C virus genotypes in Hungary using the Trugene HCV 5'NC genotyping test. ISMD2010 Eighth International Symposium on Molecular Diagnostics 2010 Graz Austria De Gruyter 2010 A21.
ZuckermanE.Liver Unit Carmel Medical Center Haifa Israel. Hepatitis C in Israel. Conversation with Razavi HA. Center for Disease Analysis Kromite Louisville CO USA 2 October 2010.
Kerzman H, 2007, Risk factors for hepatitis C virus infection among blood donors in Israel, a case–control study between native Israelis and immigrants from the former Soviet Union, 47, 1189
Lurie Y, 2007, Acute hepatitis C in Israel, a predominantly iatrogenic disease?, 22, 158
Flatau E, 1993, Prevalence of markers of infection with hepatitis B and C viruses in immigrants of operation Solomon, 1991, Isr J Med Sci, 29, 387
Stern M, 1995, A study of Israeli blood donors, asymptomatic carriers of hepatitis C virus, in relation to liver disease, cryoglobulinemia and transmission, Isr J Med Sci, 31, 277
ZuckermanE.Liver Unit Carmel Medical Center Haifa Israel. Sources for the epidemiology of hepatitis C in Israel. Conversation with Razavi HA. Center for Disease Analysis Kromite Louisville CO USA 2 August 2010.
Loebstein R, 2008, Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel, prevalence and risk factors, 10, 775
Bogomolski‐Yahalom V, 1997, Hepatitis C virus genotypes in patients with persistent infection – a preliminary report, Isr J Med Sci, 33, 18
Ministry of Health Israel, Department of Epidemiology., 2010, Infectious Diseases: Morbidity in Israel. Israel Morbidity Report
Cozzolongo R, 2009, Epidemiology of HCV infection in the general population, a survey in a southern Italian town, 104, 2740
Di Stefano R, 2002, Endemic hepatitis C virus infection in a Sicilian town, further evidence for iatrogenic transmission, 67, 339
Fabris P, 2008, Changing epidemiology of HCV and HBV infections in Northern Italy, a survey in the general population, 42, 527
Beggio M, 2007, Prevalence of hepatitis virus A, B, and C markers according to the geographic origin of medical students, G Ital Med Lav Ergon, 29, 745
Petti S, 2006, Analysis of the shift of the transmission pattern for hepatitis C in a community in Central Italy, New Microbiol, 29, 207
Pendino GM, 2005, Prevalence and etiology of altered liver tests, a population-based survey in a Mediterranean town, 41, 1151
Cecere A, 2003, High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposure, Panminerva Med, 45, 253
Proietti L, 2003, Prevalence of HCV in health care workers in Southern Italy, Clin Ter, 154, 159
Bongiorno MR, 2002, Hepatitis B and hepatitis C virus infections in dermatological patients in west Sicily, a seroepidemiological study, 16, 43
Campello C, 2002, Seroprevalence, viremia and genotype distribution of hepatitis C virus, a community-based population study in northern Italy, 30, 7
Baldo V, 2001, Prevalence of antibodies against hepatitis C virus in the elderly, a seroepidemiological study in a nursing home and in an open population. The Collaborative Group, 46, 194
Baldo V, 2000, Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North‐East Italy, a seroepidemiological study, 16, 87
Maio G, 2000, Hepatitis C virus infection and alanine transaminase levels in the general population, a survey in a southern Italian town, 33, 116
Osella AR, 1999, Molecular epidemiology of hepatitis C virus infection in an area of hyperendemicity in southern Italy, a population-based study, 37, 2371
Bellentani S, 1999, Clinical course and risk factors of hepatitis C virus related liver disease in the general population, report from the Dionysos study, 44, 874
Comandini UV, 1998, Sporadic hepatitis C virus infection, a case–control study of transmission routes in a selected hospital sample of the general population in Italy, 30, 11
Guadagnino V, 1997, Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population, a community-based survey in southern Italy, 26, 1006
Stroffolini T, 1995, High prevalence of hepatitis C virus infection in a small central Italian town, lack of evidence of parenteral exposure, 27, 235
D'Amelio R, 1995, Low prevalence of anti‐HCV antibodies among Italian Air Force recruits, Scand J Infect Dis, 27, 12
Puro V, 1993, The seroprevalence of HIV, HBV and HCV infections in patients coming to the departments of general surgery of a public hospital (S. Camillo, Rome), Minerva Chir, 48, 349
Gessoni G, 1993, Prevalence of anti‐hepatitis C virus antibodies among teenagers in the Venetian area, a seroepidemiological study, 2, 79
Pizzillo P, 2009, HCV genotypes in Sicily, is there any evidence of a shift?, 81, 1040
Cenci M, 2007, Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy, an update and report of a new method of HCV genotyping, 27, 1219
Cenci M, 2003, Prevalence of hepatitis C virus (HCV) genotypes in central Italy, Anticancer Res, 23, 5129
Dalgard O, 2003, Hepatitis C in the general adult population of Oslo, prevalence and clinical spectrum, 38, 864
Melum E, 2006, Liver TX for hepatitis C cirrhosis in a low prevalence population, risk factors and status at evaluation, 41, 592
Vik IS, 2008, Hepatitis C – a health problem also in Norway, Tidsskr Nor Laegeforen, 128, 563
Kristiansen MG, 2002, Hepatitis C in Northern Norway – an 8‐year material, Tidsskr Nor Laegeforen, 122, 1974
Eskild A, 2000, Hepatitis C virus among pregnant women in Norway – occurrence of antibodies and pregnancy outcome, Tidsskr Nor Laegeforen, 120, 1006
Dalgard O, 2009, Management of patients with hepatitis C virus genotype 2 or 3, comments on updated American Association for the Study of Liver Diseases practice guidelines, 50, 323
Kielland KB, 1991, Hepatitis A‐, B‐ and C‐markers among Norwegian drug addicts in the period 1975–89, Tidsskr Nor Laegeforen, 111, 821
DalgardO.Medical Department Oslo University Hospital Rikshospitalet Oslo Norway. Estimated incidence of hepatitis C in Norway. Conversation with Wallace C. Center for Disease Analysis Kromite Louisville CO USA 18 February 2011.
Warunek W, 1996, Epidemiologic and clinical characteristics of patients with hepatitis type C on the bases of selected parameters, Folia Med Cracov, 37, 71
Chlabicz S, 2006, Known and probable risk factors for hepatitis C infection, a case series in north-eastern Poland, 12, 141
Chlabicz S, 2004, Medical procedures and the risk of iatrogenic hepatitis C infection, case–controlled study in north-eastern Poland, 58, 204
Labedzka H, 2002, Clinical and epidemiological assessment of hepatitis C virus infection among voluntary blood donors, Med Sci Monit, 8, CR591
Borzecka B, 2007, The program of early detection of HCV infection, Przegl Epidemiol, 61, 733
Braczkowska B, 2006, Prevalence and basic determinants of hepatitis C antibodies in medical students in Katowice, Poland, Przegl Lek, 63, 539
Swincow G, 2006, Prevalence of HCV infection in infants – own clinical experience, Med Wieku Rozwoj, 10, 407
Seyfried H, 2005, Prevalence of hepatitis C virus markers in Polish blood donors in 1994–2003, Przegl Epidemiol, 59, 807
Stepien M, 2010, Hepatitis C in Poland in 2008, Przegl Epidemiol, 64, 245
Rosinska M, 2007, Hepatitis C in Poland in 2005, Przegl Epidemiol, 61, 281
Czarkowski MP., 2006, Hepatitis C in Poland in 2004, Przegl Epidemiol, 60, 481
Czarkowski MP, 2005, Hepatitis C in Poland in 2003, Przegl Epidemiol, 59, 303
Kuszewski K, 2004, Hepatitis C in Poland in 2002, Przegl Epidemiol, 58, 131
Bielak A., 2003, Hepatitis C in Poland in 2001, Przegl Epidemiol, 57, 125
Bobel D, 2008, Hepatitis C in Poland in 2006, Przegl Epidemiol, 62, 325
Mazurek J., 2002, Hepatitis C in Poland in 2000, Przegl Epidemiol, 56, 325
Laskus I, 2009, Hepatitis C in Poland in 2007, Przegl Epidemiol, 63, 251
Areias J, 2006, Epidemiological characterization of chronic hepatitis C in Portugal, Gastroenterología y hepatología, 29, 147
Santos A, 1994, Epidemiology of hepatitis C in central Portugal. Prevalence of anti‐HCV in the population of the Coimbra District, Acta Med Port, 7, S3
De Carvalho A, 2000, HCV genotypes. Liver histopathology and immunologic profile in four groups of patients, Acta Med Port, 13, 67
GoldisA.Department of Hepatogastroenterology Institute for Clinical and Experimental Medicine Prague Czech Republic. Comments on the Romania portion of HCV manuscript. Conversation with Largen A. Center for Disease Analysis Kromite Louisville CO USA 15 November 2010.
Grigorescu M., 2009, HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C, J Gastrointestin Liver Dis, 18, 45
Gheorghe L, 2005, Effectiveness and tolerability of pegylated Interferon alpha‐2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C, from clinical trials to clinical practice, 14, 109
Gheorghe L, 2007, Efficacy, tolerability and predictive factors for early and sustained virologic response in patients treated with weight‐based dosing regimen of PegIFN alpha‐2b ribavirin in real‐life healthcare setting, J Gastrointestin Liver Dis, 16, 23
Gheorghe L, 2008, Prevalence of hepatitis C in Romania, different from European rates?, 49, 661
Azoicai D, 2001, The prevalence of the owner of serologic markers for the hepatitis C virus, in a north‐eastern territory of Romania, Rev Med Chir Soc Med Nat Iasi, 105, 127
Ivan A, 1998, The epidemiological aspects and prevalence of markers in those with viral hepatitis C in some population categories in 1994–1997 in Iasi County, Bacteriol Virusol Parazitol Epidemiol, 43, 275
Ivan A, 1995, Seroepidemiological considerations of the incidence of viral hepatitis C in some population groups, Rev Med Chir Soc Med Nat Iasi, 99, 129
Molnar GB, 1994, A prevalence study of serum markers in hepatitis virus infection in the epidemiological anamnesis of the population, Bacteriol Virusol Parazitol Epidemiol, 39, 141
Paquet C, 1993, Viral hepatitis in Bucharest, Bull World Health Organ, 71, 781
Russian Federation MoH., 2000, Viral hepatitis prophylaxis, general rules of epidemiology surveillance for viral hepatitis
Gaidarenko AD., 2009, Prediction of Epidemic of Hepatitis C through Computer Simulation
Zhiburt EB, 2005, The verification of the results of screening antibodies to hepatitis C virus in blood donors, Zh Mikrobiol Epidemiol Immunobiol, 5, 71
Kuzin SN, 1999, Spread of hepatitis C and separate genotypes of hepatitis C virus in a region with a moderately active epidemic process, Vopr Virusol, 44, 79
Ariamkina OL, 1998, The diagnosis of hepatitis C viral infection in blood donors and patients, Zh Mikrobiol Epidemiol Immunobiol, 1, 74
Lytsar BN, 1993, Detection of antibodies to hepatitis C virus in blood donors, Gematol Transfuziol, 38, 29
Sychev A, 1993, The hepatitis C virus infection of Moscow blood donors, Zh Mikrobiol Epidemiol Immunobiol, 4, 80
Zhiburt EB, 1995, Specific and substitute markers of hepatitis C in screening donor blood, Gematol Transfuziol, 40, 16
Iashina TL, 1993, The spread of hepatitis C markers among the population of regions of Russia and Central Asia, Zh Mikrobiol Epidemiol Immunobiol, 5, 46
Onishchenko GG, 2000, The current problems in the epidemiology and prevention of viral hepatitis B and C in the Russian Federation, Zh Mikrobiol Epidemiol Immunobiol, 1, 50
SagalovaO.Chelyabinsk State Medical Academy Chelyabinsk Russian Federation. Hepatitis C in Russia from the Ministry of Health and Social Development. Conversation with Razavi HA. Center for Disease Analysis Kromite Louisville CO USA 15 July 2010.
Asratian AA, 2005, Tendency and analysis of the epidemic situation in parenteral virus hepatitis B and C in the Russian Federation and a number of its regions, Zh Mikrobiol Epidemiol Immunobiol, 4, 40
MaksyutovRA GavrilovaEV KanevAN.The distribution of genotypes of hepatitis C in the Russian regions. Annual All‐Russian Congress on Infectious Diseases Moscow 29–31 March 2010 Moscow 186.
Ariamkina OL., 2005, HCV infection in Ulyanovsk region. Epidemiologiia i infektsionnye bolezni, Epidemiol Infect Dis, 4, 14
Kovalev SI, 2003, Genetic variations of hepatitis C virus circulating in the Ural region, Vopr Virusol, 48, 11
L'vov DK, 1995, Prevalence of genotypes of the hepatitis C virus, circulating in northwestern and central parts of Russia, Vopr Virusol, 40, 251
Sola R, 2002, Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain, cross-sectional study, 119, 90
Prieto Domingo JJ, 1997, Prevalence of hepatitis C virus and excessive consumption of alcohol in a nonhospital worker population, Gastroenterol Hepatol, 20, 479
Suarez A, 1997, The prevalence of hepatitis A, B and C viral markers in the population of Gijon between 26 and 65 years old, Gastroenterol Hepatol, 20, 347
Ferrer F, 1997, A comparative study of two third‐generation anti‐hepatitis C virus ELISAs, Haematologica, 82, 690
Munoz‐Gomez R, 1996, Hepatitis C virus infection in Spanish volunteer blood donors, HCV RNA analysis and liver disease, 8, 273
Garcia‐Bengoechea M, 1995, Antibodies to hepatitis C virus, a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery, 7, 237
Suarez A, 1994, The prevalence of anti‐HCV positivity among blood donors in Asturias. A clinical–epidemiologic study, Med Clin, 103, 606
Martinez JL, 1991, Hepatitis C virus infection in different risk groups and among blood donors, Enferm Infecc Microbiol Clin, 9, 345
Martin Y, 1990, Incidence of anti‐HCV and ALT in blood donors, Sangre, 35, 197
Salmeron J, 1998, Epidemiology and prevalence of seropositivity for hepatitis C virus in pregnant women in Granada, Rev Esp Enferm Dig, 90, 841
Sacristan B, 1996, Seroepidemiologic study of hepatitis C virus infection in a general population from the region of La Rioja, Spain, Med Clin, 107, 331
Gil Miguel A, 1996, Prevalence of hepatitis C virus infection in school children in an urban and suburban area of Madrid, Aten Primaria, 17, 521
Garcia‐Fulgueiras A, 1996, Prevalence of hepatitis B and C markers in the south‐east of Spain, an unlinked community-based serosurvey of 2,203 adults, 28, 17
Salleras L, 1994, Seroepidemiology of hepatitis C virus infection in pregnant women in Catalonia, Med Clin, 103, 721
Jaqueti J, 1991, Prevalence of antibodies against the hepatitis C virus among the staff of a general hospital, Rev Esp Enferm Dig, 80, 33
Muga R, 2006, Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona, 1987–2001, 82, S29
Lumbreras B, 2006, Impact of hepatitis C infection on long‐term mortality of injecting drug users from 1990 to 2002, differences before and after HAART, 20, 111
Jimenez Fabrega X, 1999, The prevalence of infection by the hepatitis B, C and human immunodeficiency viruses in drug users, Aten Primaria, 24, 368
Payeras Cifre A, 1992, Hepatitis C viral infection and the consumption of intravenous drugs, Rev Sanid Hig Publica, 66, 233
Ramos B, 2007, Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus, implications for HCV therapy in HCV/HIV-coinfected patients, 54, 173
Fernandez‐Arcas N, 2006, High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain), phylogenetic and epidemiological analyses, 78, 1429
Duberg A, 2008, The epidemiology of hepatitis C virus infection in Sweden, Euro Surveill, 13, 1, 10.2807/ese.13.21.18882-en
Lidman C, 2009, Hepatitis C infection among injection drug users in Stockholm Sweden, prevalence and gender, 41, 679
European Centre for Disease Prevention and Control., 2008, Annual Epidemiological Report on Communicable Diseases in Europe 2008. Report on the State of Communicable Diseases in the EU and EEA/EFTA Countries
Widell A, 2000, Hepatocellular carcinoma in Sweden, its association with viral hepatitis, especially with hepatitis C viral genotypes, 32, 147
Westin J, 1999, Chronic hepatitis C in Sweden, genotype distribution over time in different epidemiological settings, 31, 355
Widell A, 1994, Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers, epidemiological applications, 44, 272
Prasad L, 2007, Cohort Profile, the Swiss Hepatitis C Cohort Study (SCCS), 36, 731
Federal Office of Public Health (FOPH).Health in Switzerland Switzerland 27 August 2010.
Ladewig D., 2001, A reduction in HIV positive and an increase in hepatitis C positive subjects in methadone maintenance treatments, Swiss Med Wkly, 131, 422
Russmann S, 2007, Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital, cross-sectional study, 7, 5
Ambuhl PM, 2000, Epidemiology of chronic hepatitis B and C among dialysis patients in Switzerland, Schweiz Med Wochenschr, 130, 341
Zucca E, 2000, Prevalence of Helicobacter pylori and hepatitis C virus infections among non‐Hodgkin's lymphoma patients in Southern Switzerland, Haematologica, 85, 147
Lavanchy D, 1994, Evaluation of third‐generation assays for detection of anti‐hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100‐3 antigen, J Clin Microbiol, 32, 2272, 10.1128/jcm.32.9.2272-2275.1994
Prasad LR, 2007, Hepatitis C in a sample of pregnant women in Switzerland, seroprevalence and socio-demographic factors, 137, 27
NegroF.Divisions of Clinical Pathology and of Gastroenterology and Hepatology University Hospital Geneva Switzerland. Newly diagnosed case data from the Swiss Federal Office of Public Health. Conversation with Razavi HA. Center for Disease Analysis Kromite Louisville CO USA 5 November 2010.
Swiss Federal Statistical Office.The population of Switzerland 2009 Federal Office of Statistics Bern 2010 Statistics of Switzerland. 01 Population 16pp 30 cm.
Turhan V, 2005, Investigation of the genotype distribution of hepatitis C virus among Turkish population in Turkey and various European countries, Chin Med J, 118, 1392
Keskin F, 2010, Transmission routes for chronic hepatitis C and its relation with HCV genotypes, Turk J Gastroenterol, 21, 396, 10.4318/tjg.2010.0126
Tozun N, 2010, A nationwide prevalence study and risk factors for hepatitis A, B, C,and D infections in Turkey (abstract), Hepatology, 52, 697A
Dursun M, 2004, Prevalence of Hepatitis C in adults in the south‐eastern region of Anatolia, a community-based study, 29, 75
Yildirim B, 2009, Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey, a population-based study, 20, 27
Gunduz T, 2005, Evaluation of hepatitis B surface antigen, anti‐hepatitis C virus and anti‐human immunodeficiency virus antibodies and syphilis seropositivity in blood donors, six years' seropositivity, 25, 155
Mutlu B, 2004, Seroprevalence of hepatitis B and C virus, human immunodeficiency virus and syphilis in the blood donors, Mikrobiyol Bul, 38, 445
Sakarya S, 2004, Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey, Saudi Med J, 25, 1070
Demirturk N, 2006, Hepatitis B and C virus in West‐Central Turkey, seroprevalence in healthy individuals admitted to a university hospital for routine health checks, 17, 267
Alim A, 2009, Seroprevalence of hepatitis B and C viruses, HIV, and syphilis infections among engaged couples, Saudi Med J, 30, 541
Maral I, 2009, Hepatitis B virus and hepatitis C virus seroprevalence in the elderly living in nursing homes, J Investig Med, 57, 717, 10.2310/JIM.0b013e3181ab8cab
Costella, Annastella and Health Protection Agency United Kingdom., 2008, Hepatitis C in the UK 2008. The Health Protection Agency Annual Report
Health Protection Scotland.Blood Borne Viruses and Sexually Transmitted Infections. Hepatitis C Reporting. Table 3: Persons in Scotland reported to be hepatitis C antibody positive by age group at time of earliest positive specimen and year of earliest positive specimen 2010 31 December 2009 Available athttp://www.documents.hps.scot.nhs.uk/bbvsti/annual‐data‐tables/2010/hcv‐table3‐2010‐05.pdf(accessed 17 September 2010).
Hutchinson SJ, 2006, Hepatitis C virus infection in Scotland, epidemiological review and public health challenges, 51, 8
Goldberg D, 2008, Hepatitis C Action Plan for Scotland: Phase II (May 2008–March 2011), Euro Surveill, 13, 1, 10.2807/ese.13.21.18876-en
Sweeting MJ, 2009, Hepatitis C infection among injecting drug users in England and Wales (1992–2006), there and back again?, 170, 352
Roy KM, 2007, Hepatitis C virus infection among injecting drug users in Scotland, a review of prevalence and incidence data and the methods used to generate them, 135, 433
Judd A, 2005, Incidence of hepatitis C virus and HIV among new injecting drug users in London, prospective cohort study, 330, 24
Hope VD, 2001, Prevalence of hepatitis C among injection drug users in England and Wales, is harm reduction working?, 91, 38
Taylor A, 2000, Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990–1996, are current harm reduction strategies working?, 40, 176
Lamden KH, 1998, Hepatitis B and hepatitis C virus infections, risk factors among drug users in Northwest England, 37, 260
Watson JP, 1996, Hepatitis C virus, epidemiology and genotypes in the north east of England, 38, 269
Hutchinson SJ, 2004, Hepatitis C virus among childbearing women in Scotland, prevalence, deprivation, and diagnosis, 53, 593
Goldberg D, 2001, Hepatitis C virus among high and low risk pregnant women in Dundee, unlinked anonymous testing, 108, 365
Ward C, 2000, Prevalence of hepatitis C among pregnant women attending an inner London obstetric department, uptake and acceptability of named antenatal testing, 47, 277
Saiz dlH, 2011, Hepatitis C and B prevalence in Spanish prisons, Eur J Clin Microbiol Infect Dis, 10.1007/s10096-011-1166-5
Gish RG, 2005, Management of hepatitis C virus in special populations, patient and treatment considerations, 3, 311
Gerlach JT, 2003, Acute hepatitis C, high rate of both spontaneous and treatment-induced viral clearance, 125, 80
Jauffret‐Roustide M, 2006, Impact of a harm‐reduction policy on HIV and hepatitis C virus transmission among drug users, recent French data – the ANRS-Coquelicot Study, 41, 1603
Garfein RS, 1996, Viral infections in short‐term injection drug users, the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses, 86, 655